SCHEDULE: Bradley Burnam Discloses 52.76% Stake in Turn Therapeutics

Bradley Burnam has filed a Schedule 13G reporting beneficial ownership of 15,716,260 shares of Turn Therapeutics Inc. common stock.

Summary

• Bradley Burnam reports beneficial ownership of 15,716,260 shares of Turn Therapeutics Inc. common stock.
• This stake represents 52.76% of the company's total outstanding common stock.
• The shares are held of record by BEB Holdings, LLC, an entity for which Mr. Burnam is the sole member.
• The ownership total includes shares issuable upon the exercise of stock options exercisable within 60 days of April 2, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral regulatory disclosure confirming existing control, which provides transparency but does not impact the company's fundamental financial performance.

Positives

• Significant insider alignment with 52.76% of the company controlled by a single reporting person.
• Clear disclosure of beneficial ownership structure via BEB Holdings, LLC.

Negatives

• High concentration of voting and dispositive power in a single individual may limit minority shareholder influence.

Risks

• Concentration of ownership could lead to potential conflicts of interest or reduced liquidity for other shareholders.
• Reliance on the exercise of stock options to reach the reported ownership threshold.

Future Outlook

The filing does not provide forward-looking business guidance, as it is a regulatory disclosure of ownership status.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are standard regulatory requirements for significant shareholders and do not typically signal a change in operational strategy, but rather confirm the existing control structure within the biotechnology sector.

Comparison to Industry Standards

• The ownership level of 52.76% is consistent with founder-led biotechnology companies where early investors or executives maintain majority control.
• The filing follows standard SEC reporting requirements for beneficial owners under Rule 13d.

Related Party Transactions

• The reporting person, Bradley Burnam, is the sole member of BEB Holdings, LLC, which holds the shares.

Stakeholder Impact

• Shareholders should note the high concentration of voting power held by the reporting person.

Next Steps

• Continued monitoring of future SEC filings for any changes in beneficial ownership or potential divestment activities.

Key Dates

Keywords

Turn Therapeutics, Schedule 13G, Bradley Burnam, Beneficial Ownership, Insider Holdings, BEB Holdings